Intellectual property (IP) rights in general and patents in particular are commonly characterized as, at best, a necessary “monopoly” granted to correct weak private incentives to invest in generating innovations that can be easily imitated by others. In… Read More »
For more than a decade, almost every branch of the federal government has taken steps to restrain what has been perceived to be an “explosion” of patent issuance and litigation. The results have been palpable. A patent… Read More »
For a change, some good news: The Journal reports that the Biden administration is in the early stages of building a “tech alliance” against China. The Trump administration began working with the Netherlands to block the sale… Read More »
Each year, Black History Month allows us to reflect on so many great Black Americans who’ve contributed to the success of our nation. We reflect on the contributions of many well-known and not so well-known Black Americans…. Read More »
Advocates for “patent reform” have long argued that reducing patent protection will open up markets and accelerate innovation by lowering entry barriers and expanding access to existing technologies. Yet, over 15 years of patent reform since the… Read More »
When Joe Biden became President-elect Biden, he asked us to imagine a new, more hopeful version of America. He urged us to work toward leaving a “grim era” behind – a COVID-19 outbreak, economic devastation, social unrest,… Read More »
I remember my first IBM patent. Granted to my colleagues and myself in 2005, it was for a topcoat waterproof material for a photoresist—a light-sensitive substance used to make circuit patterns for semiconductor chips. It was a proud moment… Read More »
Giant tech companies have come under a great deal of well-deserved criticism from across the political spectrum on a variety of concerns over their actions. On market power, privacy, political bias and disinformation, they are under a… Read More »
At a time when innovative American companies are moving technology forward at often dizzying rates, today’s Federal Trade Commission (FTC) seems to be bent on thwarting that innovation by taking a giant leap backwards by pitting antitrust… Read More »
This fall, tens of millions of Americans will get vaccinated against influenza — but they won’t all experience a prick in the arm. Instead, many will take FluMist, the painless nasal flu vaccine. FluMist is just one… Read More »
